Omada Health (NASDAQ:OMDA) Price Target Raised to $25.00

Posted by Brian Himes on Aug 15th, 2026

Omada Health (NASDAQ:OMDA – Free Report) had its target price raised by Robert W. Baird from $15.00 to $25.00 in a research note published on Wednesday morning, MarketBeat.com reports. The firm currently has a neutral rating on the stock.

Several other research firms also recently commented on OMDA. Canaccord Genuity Group upped their price objective on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a report on Monday, July 20th. Weiss Ratings cut Omada Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, July 13th. Citizens Jmp boosted their price target on Omada Health from $21.00 to $27.00 and gave the company a “market outperform” rating in a report on Monday, July 20th. Finally, Barclays upped their price objective on Omada Health from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Get Our Latest Report on Omada Health

Omada Health Stock Performance

Shares of OMDA stock opened at $24.04 on Wednesday. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 480.80 and a beta of 1.73. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The stock’s 50-day simple moving average is $20.99 and its 200-day simple moving average is $16.49.

Omada Health (NASDAQ:OMDA – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, equities analysts forecast that Omada Health will post -0.01 earnings per share for the current year.

Insider Transactions at Omada Health

In other news, CFO Steven L. Cook sold 33,000 shares of the stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the sale, the chief financial officer directly owned 133,359 shares of the company’s stock, valued at $2,652,510.51. This represents a 19.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sean P. Duffy sold 25,886 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total value of $587,094.48. Following the sale, the chief executive officer owned 411,861 shares in the company, valued at $9,341,007.48. This trade represents a 5.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 254,726 shares of company stock valued at $5,370,496. Insiders own 6.38% of the company’s stock.

Institutional Trading of Omada Health

A number of institutional investors and hedge funds have recently made changes to their positions in OMDA. Quarry LP acquired a new position in shares of Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in shares of Omada Health during the 4th quarter valued at approximately $32,000. Raymond James Financial Inc. acquired a new stake in Omada Health in the 2nd quarter valued at $32,000. Versant Capital Management Inc grew its stake in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares during the period. Finally, Strs Ohio increased its holdings in Omada Health by 151.0% in the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after acquiring an additional 2,567 shares in the last quarter.

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.